Prudentia Group

Noida, India Founded: 2012 • Age: 14 yrs Acquired By PrimeVigilance
Offers coding, consulting, and managed services for pharmacovigilance in pharmaceuticals.

About Prudentia Group

Prudentia Group is a company based in Noida (India) founded in 2012 by Pushpendra Gupta was acquired by PrimeVigilance in September 2025. It operates as a B2B. The company has 53 employees. Prudentia Group offers products and services including MedCodr, PV Trend, E2B Bridge, Coding Services, and Consulting Services. Prudentia Group operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.

Key Metrics
  • Annual Revenue
    ₹36.83 Cr

    FY 2025 · +167% YoY

  • Net Profit
    ₹5.41 Cr

    FY 2025 · 15% margin

  • EBITDA
    ₹7.70 Cr

    FY 2025 · 21% margin

  • Investors
  • Employee Count
    53
  • Acquired by

Products & Services of Prudentia Group

Prudentia Group offers a comprehensive portfolio of products and services, including MedCodr, PV Trend, E2B Bridge, Coding Services, and Consulting Services.

MedCodr
Software Tool

Web-based solution for coding medical terms to dictionaries

PV Trend
Data Analysis Tool

Tool for querying pharmacovigilance data sources

E2B Bridge
Conversion Tool

Solution for converting E2B files in safety databases

Coding Services
Consulting Service

Services for MedDRA and WHODrug term coding

Consulting Services
Advisory Service

Process and technology consulting for drug safety

Managed Services
Support Service

Administration of safety databases and technical support

Investors in Prudentia Group

Prudentia Group has secured backing from 1 investor. Prominent investors backing the company include PrimeVigilance.

All
InvestorDescriptionFounded YearDomainLocation
Functional CRO offering pharmacovigilance services
2008primevigilance.comGuildford, United Kingdom
Premium access

Investor details for Prudentia Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Prudentia Consulting India Private Limited (Prudentia Group)

Prudentia Consulting India Private Limited is the primary company behind Prudentia Group. The board of Prudentia Consulting India Private Limited currently have 3 directors; the longest-serving is Dragan Kovacevic, appointed in 2025. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Dragan Kovacevic
DIN 08209486
Additional Director01 Apr 20251 yr 6 moPrudentia Consulting India Private Limited
Salem Sally Amanuel Araya
DIN 09723467
Additional Director01 Apr 20251 yr 6 moPrudentia Consulting India Private Limited
Rahul Agarwal
DIN 08204328
Additional Director05 May 20251 yr 5 moPrudentia Consulting India Private Limited

People of Prudentia Group

10 people are tracked at Prudentia Group (4 in leadership, 6 in team); the tracked headcount is 53.

NameRoleGroup
Pushpendra Gupta
Co-FounderLeadership
Vineet Singh
Vice PresidentLeadership
Maxwell Khoza
CEOLeadership
Krishna Patel
PartnerLeadership
Pushpinder Kaur
Human Resources AssociateTeam
Malvika Bhardwaj
Finance ExecutiveTeam
Nadine Kellar
Human Resources Office ManagerTeam
Shivam Garg
Principal ConsultantTeam
Ankit Maindola
Associate Principal ConsultantTeam
Kakoli Goswami
Associate Principal ConsultantTeam
Premium access

Complete people profiles for Prudentia Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Prudentia Group

Figures of Prudentia Consulting India Private Limited, the primary company behind Prudentia Group, for FY 2025. Revenue was ₹36.83 Cr (+167% year on year). Net profit was ₹5.41 Cr (15% margin). EBITDA was ₹7.70 Cr (21% margin). Revenue has grown at a compounded annual rate of +280% over three years and +111% over five years.

  • ₹36.83 CrRevenue · FY 2025 · +167% YoY
  • ₹5.41 CrNet profit · 15% margin
  • ₹7.70 CrEBITDA · 21% margin
  • ₹1 LakhPaid-up capital
  • 53Employees (provident fund records)
  • +280%Revenue CAGR, 3 years
  • +111%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Prudentia Consulting India Private Limited are on its company page.

Premium access

Detailed financial statements for Prudentia Group

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Prudentia Group

2 dated milestones of Prudentia Group across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Prudentia Group is founded.
  2. Exit Acquired by PrimeVigilance.

Competitors of Prudentia Group

Prudentia Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$255.15M350
Suite solutions are provided for payers and healthcare providers.
zuelligpharma.com1992Singapore––
Healthcare access in Asia is enhanced by Zuellig Pharma.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clinigengroup.com2010Burton-on-trent, United Kingdom––
Specialty medicines are supplied via clinical trials and access programs.
sciencegroup.com1995Cambridge, United Kingdom–431
Technology-based consultancy and product development services are provided.
clearviewhcp.com2008Newton, United States–381
Strategic consulting services are provided to life sciences companies.
fabtechnologies.com2002Mumbai, India$175,048279
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured.
Premium access

Detailed competitors of Prudentia Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Prudentia Group

CIMIC's Sedgman acquires Prudentia
Miningmagazine β€’ 2 years ago
WCG, Prudentia Enter Pharmacovigilance Alliance
Contractpharma β€’ 7 years ago
WCG Partners with Prudentia Group
Newyork β€’ 7 years ago
Prudential reveals new CEO as Strangfeld steps down
Intelligentinsurer β€’ 8 years ago
Premium access

Complete news archive for Prudentia Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Prudentia Group

10 companies that operate in the same segment as Prudentia Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Prudentia Group

Prudentia Group was founded in 2012.

Prudentia Group is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Prudentia Group has 53 employees.

The primary company behind Prudentia Group, Prudentia Consulting India Private Limited, reported revenue of β‚Ή36.83 Cr for FY 2025, up 167% year on year.

Prudentia Group specializes in drug safety and pharmacovigilance management, providing consulting, coding, and managed services to pharmaceutical companies. They develop innovative products like MedCodr for medical term coding and PV Trend for data analysis. Based in Noida, India, and New Jersey, USA, they support global clients with technology solutions for safety database administration and process consulting.

Prudentia Group's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Prudentia Group offers MedCodr, PV Trend, E2B Bridge, Coding Services, and 2 more products and services.

Prudentia Group has 1 investor. Key investors include PrimeVigilance.

Prudentia Group operates through Prudentia Consulting India Private Limited.

Yes. Prudentia Group was acquired by PrimeVigilance in September 2025.

The legal entities of Prudentia Group currently have 3 directors, including Dragan Kovacevic, Rahul Agarwal, Salem Sally Amanuel Araya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available